DNMT3A and hepatocellular carcinoma: To gain insights into the molecular mechanism underlying the role of DNMT3a in HCC, CRISPR-CAS9 was used to delete DNMT3a from HEPG2 and HUH7 cells, the effect of DNMT3a depletion on the expression of genes involved in JAK/STAT3 signaling pathway was examined.